Lianxin Liu

机构：University of Science and Technology of China, Anhui Provincial Hospital · ORCID：0000-0002-3535-6467

发表论文 298 篇 · 总被引 10065 次 · h-index 49

代表论文

• China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition) (2025 · Liver Cancer · 被引 41)
• Glucose restriction shapes pre-metastatic innate immune landscapes in the lung through exosomal TRAIL (2025 · Cell · 被引 34)
• RIOK1 phase separation restricts PTEN translation via stress granules activating tumor growth in hepatocellular carcinoma (2025 · Nature Cancer · 被引 24)
• Glycolytic enzyme PFKFB4 governs lipolysis by promoting de novo lipogenesis to drive the progression of hepatocellular carcinoma (2025 · Cancer Letters · 被引 8)
• Biomarker, efficacy and safety analysis of transcatheter arterial chemoembolization combined with atezolizumab and bevacizumab for unresectable hepatocellular carcinoma (2025 · Cancer Immunology Immunotherapy · 被引 4)
• Risk Factors for Recurrence in Patients with Hepatocellular Carcinoma After Curative Resection or Ablation (2025 · Journal of Hepatocellular Carcinoma · 被引 3)